242 related articles for article (PubMed ID: 16569586)
1. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma?
Khan G
Exp Hematol; 2006 Apr; 34(4):399-406. PubMed ID: 16569586
[TBL] [Abstract][Full Text] [Related]
2. Screening for Epstein-Barr virus in Hodgkin's lymphoma.
Khan G
Methods Mol Biol; 2009; 511():311-22. PubMed ID: 19347303
[TBL] [Abstract][Full Text] [Related]
3. [Current views of the histogenesis and pathogenesis of Hodgkin lymphoma].
Leenman EE
Arkh Patol; 2007; 69(5):7-11. PubMed ID: 18074812
[TBL] [Abstract][Full Text] [Related]
4. High frequency of t(14;18) in Hodgkin's lymphoma associated with follicular lymphoma.
Yoshida M; Ichikawa A; Miyoshi H; Takeuchi M; Kimura Y; Nino D; Ohshima K
Pathol Int; 2012 Aug; 62(8):518-24. PubMed ID: 22827759
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-induced B-cell proliferation of Hodgkin's and Reed-Sternberg cell pheno- and genotype may develop in peripheral T-cell lymphomas.
Pajor L; Kajtár B; Jáksó P; Lacza A; László R; Radványi G; Mórocz I; Tóth A; Varga G
Histopathology; 2006 Nov; 49(5):553-7. PubMed ID: 17064310
[No Abstract] [Full Text] [Related]
6. The molecular pathogenesis of Hodgkin lymphoma.
Farrell K; Jarrett RF
Histopathology; 2011 Jan; 58(1):15-25. PubMed ID: 21261680
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited.
Benharroch D; Einav I; Feldman A; Levy A; Ariad S; Gopas J
APMIS; 2010 May; 118(5):339-45. PubMed ID: 20477808
[TBL] [Abstract][Full Text] [Related]
8. [Hodgkin's disease and Epstein-Barr virus].
Depil S; Moralès O; Auriault C
Ann Biol Clin (Paris); 2004; 62(6):639-48. PubMed ID: 15563422
[TBL] [Abstract][Full Text] [Related]
9. [Physiopathology of Hodgkin's disease].
Gaulard P; Kanavaros P
Rev Prat; 1998 May; 48(10):1065-9. PubMed ID: 9781149
[TBL] [Abstract][Full Text] [Related]
10. Lymphomagenesis in Hodgkin lymphoma.
Matsuki E; Younes A
Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205
[TBL] [Abstract][Full Text] [Related]
11. [Presence of human cytomegalovirus within the neoplastic cells of Hodgkin's disease].
Huang GS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):403-5. PubMed ID: 12940088
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells.
Dinand V; Dawar R; Arya LS; Unni R; Mohanty B; Singh R
Eur J Cancer; 2007 Jan; 43(1):161-8. PubMed ID: 17113770
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated Hodgkin's lymphoma.
Gandhi MK; Tellam JT; Khanna R
Br J Haematol; 2004 May; 125(3):267-81. PubMed ID: 15086409
[TBL] [Abstract][Full Text] [Related]
14. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
Huang Q; Wilczynski SP; Chang KL; Weiss LM
Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
[TBL] [Abstract][Full Text] [Related]
15. Reed-Sternberg-like cells in lymph node aspirates in the absence of Hodgkin's disease: pathologic significance and differential diagnosis.
Iacobuzio-Donahue CA; Clark DP; Ali SZ
Diagn Cytopathol; 2002 Dec; 27(6):335-9. PubMed ID: 12451562
[TBL] [Abstract][Full Text] [Related]
16. [Hodgkin's disease: biology can help the physician towards new prognostic factors and new therapeutic approaches].
Rubio MT; Ghesquières H; Blay JY; Salles G
Bull Cancer; 2001 Nov; 88(11):1081-90. PubMed ID: 11741802
[TBL] [Abstract][Full Text] [Related]
17. [Factors involved in host-pathogen interaction for the risk of Hodgkin lymphoma induced by Epstein Barr virus].
Torres Espíndola LM; Arellano Galindo J; Velazquez Cruz R; Castillejos López Mde J
Invest Clin; 2013 Sep; 54(3):311-24. PubMed ID: 24354244
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and Hodgkin's lymphoma.
Andersson J
Herpes; 2006 May; 13(1):12-6. PubMed ID: 16732997
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanisms of classic Hodgkin's lymphoma.
Felberbaum RS
Yale J Biol Med; 2005 Jul; 78(4):203-10. PubMed ID: 16720015
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.
Chuang HC; Lay JD; Hsieh WC; Su IJ
Cancer Sci; 2007 Sep; 98(9):1281-7. PubMed ID: 17627615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
